Glenview Capital Management 13F, Q4 2023
Larry Robbins · quarter ending 31 December 2023 · filed 14 February 2024 · SEC CIK 1138995
Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 3 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.
Largest positions, Q4 2023
The 25 largest of 41 positions. Weights are against the whole filed book. Changes are in shares held, against the Q3 2023 filing.
| Company | Ticker | Value | % of book | vs Q3 2023 |
|---|---|---|---|---|
| THE CIGNA GROUP | CI | $641.58M | 14.9% | +38% shares |
| TENET HEALTHCARE CORP | THC | $585.09M | 13.6% | +13% shares |
| DXC TECHNOLOGY CO | DXC | $297.46M | 6.9% | +34% shares |
| UNIVERSAL HLTH SVCS INC | UHS | $259.36M | 6.0% | -3% shares |
| GLOBAL PMTS INC | GPN | $247.41M | 5.8% | +6% shares |
| CLARIVATE PLC | $228.27M | 5.3% | +22% shares | |
| CORTEVA INC | CTVA | $225.16M | 5.3% | +117% shares |
| ALIGHT INC | ALITEUR | $155.26M | 3.6% | +11% shares |
| MCKESSON CORP | MCK | $151.35M | 3.5% | -9% shares |
| FISERV INC | FISV | $125.30M | 2.9% | -26% shares |
| UBER TECHNOLOGIES INC | UBER | $120.95M | 2.8% | -7% shares |
| EXPEDIA GROUP INC | EXPE | $106.44M | 2.5% | -13% shares |
| AMAZON COM INC | AMZN | $105.46M | 2.5% | -27% shares |
| MYRIAD GENETICS INC | MYGN | $101.14M | 2.4% | +40% shares |
| BROOKDALE SR LIVING INC | BKD | $98.62M | 2.3% | -9% shares |
| VALVOLINE INC | VVV | $87.19M | 2.0% | -8% shares |
| ELEMENT SOLUTIONS INC | ESI | $87.07M | 2.0% | +35% shares |
| US FOODS HLDG CORP | USFD | $79.64M | 1.9% | -22% shares |
| HCA HEALTHCARE INC | HCA | $68.08M | 1.6% | -24% shares |
| VIATRIS INC | VTRS | $65.68M | 1.5% | new |
| CVS HEALTH CORP | CVS | $58.92M | 1.4% | new |
| META PLATFORMS INC | META | $55.62M | 1.3% | +185% shares |
| KNIGHT-SWIFT TRANSN HLDGS IN | KNX | $49.32M | 1.1% | -16% shares |
| CHARTER COMMUNICATIONS INC N | CHTR | $45.45M | 1.1% | -32% shares |
| DUN & BRADSTREET HLDGS INC | $45.16M | 1.1% | +75% shares |
What changed since Q3 2023
Against the Q3 2023 filing, Glenview Capital Management opened 6 new positions, added to 14, trimmed 17, left 4 unchanged and exited 12. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Exited
- ATVIEURwas $110.65M
- APTIV PLCwas $81.19M
- TFXwas $74.78M
- DWDPEURwas $32.27M
- AVTRwas $21.50M
- MASI*was $18.31M
- MEDTRONIC PLCwas $14.10M
- MSFTwas $9.45M
and 4 more
Other quarters
Source: SEC Form 13F-HR, accession 0000905148-24-000708, filed by GLENVIEW CAPITAL MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.